Oral lipid based drug delivery system (LBDDS): Formulation, characterization and application: A review

Current Drug Delivery

Volumn 8, Issue 4, 2011, Pages 330-345

  Rahman, Md Akhlaquer ^a,c   Harwansh, Ranjit ^a   Mirza, Mohd Aamir ^b   Hussain, Sarfaraj ^c   Hussain, Arshad ^c  

^a GURU GHASIDAS UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

^c INTEGRAL UNIVERSITY   (India)

Author keywords

Bioavailability; Co surfactant; Oral absorption; Self micro nanoemulsifying drug delivery system (SMEDDS SNEDDS); Solubility; Surfactant

Indexed keywords

ACYLGLYCEROL; AVODAT; BEXAROTENE; CLOFAZIMINE; COSURFACTANT; CYCLOSPORIN; CYCLOSPORIN A; DRONABINOL; DRUG CARRIER; FORTAVASE; GELATIN; HALOFANTRINE; HECTROL; ISOTRETINOIN; LIPID; NANOSTRUCTURED LIPID CARRIER; NEROL; OIL; PHOSPHATIDYLCHOLINE; PLANT EXTRACT; PROGESTERONE; PUERARIA LOBATA EXTRACT; PUERARIN; RETINOIC ACID; RITONAVIR; ROCATROL; SILIBININ; SOLID LIPID NANOPARTICLE; SOLVENT; SURFACTANT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; WATER;

ADSORPTION; AEROSOL; AQUEOUS SOLUTION; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; DISPERSION; DROPLET SIZE ANALYSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ELECTRIC CONDUCTIVITY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; FLOW KINETICS; HUMAN; HYDROLYSIS; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; LIPID BASED DRUG DELIVERY SYSTEM; LIPID METABOLISM; LIPOLYSIS; MICROEMULSION; NANOEMULSION; NONHUMAN; PARTICLE SIZE; POLARIZATION MICROSCOPY; PRIORITY JOURNAL; REFRACTION INDEX; REVIEW; SELF EMULSIFYING DRUG DELIVERY SYSTEM; SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM; TENSION; THERMODYNAMICS; TRADITIONAL MEDICINE; TURBIDIMETRY; ULTRAVIOLET SPECTROPHOTOMETRY; VISCOSITY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EMULSIFYING AGENTS; HUMANS; LIPIDS;

EID: 79959350104     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720111795767906     Document Type: Review

References (134)

1. Hoar, T.P.; Schulman, J.H. Transparent water-in-oil dispersions: the oleopathic hydro-micelle. Nature., 1943, 152, 102-103.
2. Schulman, J.H.; Stoeckenius, W.; Prince, L.M. Mechanism of formation and structure of microemulsions by electron microscopy. J. Phys. Chem., 1959, 63, 1677-1680.
3. Danielsson, I.; Lindman, B.; The definition of a microemulsion. Colloids and Surfaces., 1981, 3, 391-392.
4. Sintov, A.C.; Shapiro, L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailabil-ity in-vivo. J. Control. Release., 2004, 95, 173-183.
5. Morel, S.; Ugazio, E.; Cavalli, R.; Gasco, M.R. Thymopentin in solid lipid nanoparticles. Int. J. Pharm., 1996, 132, 259-261.
6. Shinoda, K.; Lindman, B. Organized surfactant systems: microe-mulsions. Langmuir., 1987, 3, 135-149.
7. Carey, M.C.; Small, D.M.; Bliss, C.M. Lipid digestion and absorption. Annu. Rev. Physiol., 1983, 45, 651-677.
8. Hamosh, M.; Scanon, J.W.; Ganot, D.; Like, M.; Scanlon, K.B.; Hamosh, P. Fat digestion in the newborn: characterization of lipase in gastric aspirates of premature and term infants. J. Clin. Invest., 1981, 67, 838-846.
9. Liao, C.; Jarowski, C.I. Dissolution rates of corticoid solutions dispersed on silicas. J. Pharm. Sci., 1984, 73, 401-403.
10. Bemback, S.; Blackberg, L.; Hemell, O. Fatty acids generated by gastric lipase promote human milk triacylglycerol digestion by pancreatic colipase-dependent lipase. Biochim. Biophys. Acta., 1989, 101, 286-293.
11. Borgstrom, B. Importance of phosphohpids, pancreatic phospholi- pase A, and fatty acid for the digestion of dietary fat. Gastroen- terology., 1980, 78, 954-962.
12. Patton, I.S.; Vetter, R.D.; Hamosh, M.; Borgstrom, B.; Lindstrom, M.; Carey, M.C. The light microscopy of triglyceride digestion. Food Microstructure., 1985, 4, 29-41.
13. Charman, S.A.; Charman, W.N.; Rogge, M.C; Wilson, T.D.; Dukto, F.J.; Pouton, C.W. Self-emulsifying drug delivery systems: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm. Res., 1992, 9, 87-93.
14. Pouton, C.W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur. J. Pharm. Sci., 2000, 11(2), S93-S98.
15. Greiner, R.W.; Evans, D.F. Spontaneous formation of a water-continuous emulsion from water-in-oil microemulsion. Langmuir., 1990, 6, 1793-1796.
16. Shah, N.H.; Caravajal, M.T.; Patel, C.L.; Infeld, M.H.; Malick, A.W. Self-emulsifying drug delivery systems (SEDDS) with poly-glycolyzed glycerides for improving in-vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm., 1994, 106, 15-23.
17. Craig, D.Q.M.; Lievens, H.S.R.; Pitt, K.G.; Storey, D.E. An investigation into the physicochemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int. J. Pharm., 1993, 96, 147-155.
18. Jannin, V.; Musakhanian, J.; Marchaud, D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev., 2008, 60, 734-746.
19. Father, I.; Gupte, S.V.; Khankari, R.K.; Hontz, J.; Robinson, J.R.; Eichman, J.D. Newton, R M.; Petterson, J.; Podczeck, F.; Clarke, A.; Booth, S. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J. Pharm. Sci., 2001, 90, 987-995.
20. Kim, C.; Shin, H.; Yang, S.; Kim, J.; Oh, Y. Once-a-day oral dosing regimen of Cyclosporin A: Combined therapy of Cyclosporin A premicroemulsion concentrates and enteric coated solid-state pre-microemulsion concentrates. Pharm. Res., 2001, 18, 454-459.
21. Takashima, Y.; Yuasa, H.; Kanaya, Y.; Nomura, I.; Shinozawa, K. Reduction of tablet coloration at tableting for oily medicine (to-copheryl nicotinate). Int. J. Pharm., 1999, 187, 125-135.
22. Yang, J.; Her, J.W. Gas-assisted IR-ATR probe for detection of volatile compounds in aqueous solutions. Anal. Chem., 1999, 71, 1773-1779.
23. Spireas, S.S.; Jarowski, C.L.; Rohera, B.D. Powdered solution technology: principles and mechanism. Pharm. Res., 1992, 9, 1351-1358.
24. Spireas, S.; Sadu, S.; Grover, R. In vitro release evaluation of hy-drocortisone liquisolid tablets. J. Pharm. Sci., 1998, 87, 867-872.
25. Monduzzi, M.O.; Ambrosone, L. Microemulsions and emulsions in DDAB/water/oil systems. Colloids Surfaces A: Physicochem. Eng. Aspects., 1999, 160, 23-36.
26. Sheth, A.; Jarowski, C.I. Use of powdered solutions to improve the dissolution rate of polythiazide tablets. Drug Dev. Ind. Pharm., 1990, 16, 769-777.
27. DeHaan, P.; Poels-Janssen, H.G.M. Solid pharmaceutical composition comprising an excipient capable of binding water. US Patent No. 6,187,339, 2001.
28. Alderborn, G.; Nystrom, C. Studies on direct compression of tablets. Part 4. Effect of particle size on the mechanical strength of tablets. Acta. Pharm. Suec., 1982, 19, 381-390.
29. Duberg, M.; Nystrom, C. Studies on direct compression of tablets. Part 6. Evaluation of methods for the estimation of particle fragmentation during compaction. Acta. Pharm. Suec., 1982, 19, 421-436.
30. Sun, C.; Grant, D.J.W. Effect of initial particle size on the tableting properties of L-lysine monohydrochloride dihydrate powder. Int. J. Pharm., 2001a, 215, 221-228.
31. Sun, C.; Grant, D.J.W. Influence of elastic deformation of particles on Heckel analysis. Pharm. Dev. Tech., 2001b, 6, 193-200.
32. Sun, C.; Grant, D.J.W. Compaction properties of L-lysine salts. Pharm. Res., 2001c, 18, 281-286.
33. Ragnarsson, G.; Sjogren, J. Force displacement measurements in tableting. J. Pharm. Pharmacol., 1985, 37, 145-150.
34. Eriksson, M.; Nystrom, C.; Alderborn, G. Evaluation of a per-meametry technique for surface area measurements of coarse par-ticulate materials. Int. J. Pharm., 1990, 63, 189-199.
35. Heckel, R.W. An analysis of powder compaction phenomena. Trans. Metall. Soc. AIME., 1961a, 221, 1001-1008.
36. Heckel, R.W. Density-pressure relationship in powder compaction. Trans. Metall. Soc. AIME., 1961b, 221, 671-675.
37. Bummer, P.M. Physical chemical considerations of lipid-based oral drug delivery- solid lipid nanoparticles. Crit. Rev. Ther. Drug carr. Syst., 2004, 21, 1-19.
38. Constantinides, P.P. Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm. Res., 1995, 12, 1561-1572.
39. Lawrence, M.J.; Rees, G.D. Microemulsion based media as a novel drug delivery system. Adv. drug delivery. Rev., 2002, 45, 89-121.
40. Wakerly, M.G.; Pouton, C.W.; Meakin, B.J.; Morton, F.S. Self-emulsification of vegetable oil -nonionic surfactant mixture: a proposed mechanism of action. ACS Symp. Ser., 1986. 311, 242-255.
41. Craig, D.Q.M.; Barker, S.A.; Banning, D.; Booth, S.W. An investigation into the mechanism of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm., 1995, 114, 103-110.
42. Attwood, D. Microemulsions. In Colloidal drug Delivery Systems. J. Kreuter., Ed.; Marcel Dekker.; New York, 1994, pp. 31-71.
43. Bhargava, H.N.; Namrkar, A.; Lieb, L.M. Using microemulsions for drug delivery. Pharm. Tech., 1987, 11, 46-52.
44. Eccleston, J. Microemulsions. In Encyclopedia of Pharmaceutical Technology Vol. 9. J. Swarbrick and J.C. Boylan, Ed.; Marcel Dekker, New York., 1994, pp. 375-421.
45. Lawrence, M.J. Surfactant systems: microemulsions and vesicles as vehicles for drug delivery. Eur. J. Drug Metab. Pharmacokinet., 1994, 3, 257-269.
46. Lawrence, M.J. Microemulsions as drug delivery vehicles. Curr. Opin. Colloid Interface Sci., 1996, 1, 826-832.
47. Tenjarla, S. Microemulsions: an overview and pharmaceutical applications. Crit. Rev. Ther. Drug Carrier Systems., 1999, 16, 461-521.
48. Osborne, D.W.; Middleton, C.A.; Rogers, R.L. Alcohol-free micro-emulsions. J. Dispersion Sci. Technol., 1988, 9, 415-423.
49. Sagitani, H.; Friberg, S. Microemulsion systems with a non-ionic co-surfactant. J. Disper. Sci. Technol., 1980, 1, 151-164.
50. Attwood, D.; Mallon, C.; Taylor, C.J. Phase studies of oil-in-water phospholipid microemulsions. Int. J. Pharm., 1992, 84, R5-R8.
51. Aboofazeli, R.; Lawrence, C.B.; Wicks, S.R.; Lawrence, M.J. Investigations into the formation and characterization of phosphol-ipid microemulsions. III. Pseudo-ternary phase diagrams of systems containing water-lecithin-isopropyl myristate and either an al-kanoic acid, amine, alkanediol, polyethylene glycol alkyl ether or alcohol as co-surfactant. Int. J. Pharm., 1994, 111, 63-72.
52. Warisnoicharoen, W.; Lansley, A.B., Lawrence, M.J. Light scattering investigations on dilute non-ionic oil-in-water microemulsions. AAPS Pharm. Sci., 2000, 2, 429-448.
53. Barnes, I.S.; Hyde, S.T.; Ninham, B.W.; Derian, P.; Drifford, M.; Wan G.G.; Zemb T.N. The disordered open connected model of microemulsions. Progr. Colloid. Polym. Sci., 1988, 76, 90-95.
54. D'Angelo, M.; Fioretto, D.; Onori, G.; Palmieri, L.; Santiicci, A. Dynamics of water-containing sodium bis (2-ethylhexyl) sulfosuc-cinate (AOT) reverse micelles: a high-frequency dielectric study. Phys. Rev., 1996, E54, 993-996.
55. Eastoe, J.; Fragneto, G.; Robinson, B.H., Towey, T.F., Heenan, R.K., Lena, F.J. Variation of surfactant counter ion and its effect on the structure and properties of Aerosol-OT-based water-in-oil mi-croemulsions. J. Chem. Soc., 1992, 88, 461-467.
56. Johnston, K.A.; Shah, D.O. Effect of oil chain length and electrolytes on water solubilization in alcohol-free pharmaceutical micro-emulsions. J. Colloid Interface Sci., 1985, 107, 269-271.
57. Larche, F.C.; Delord, P. Structures and stability of isotropic phases in the AOT decane- water system. Fluid Phase Equilib., 1985, 20, 257-64.
58. Skodvin, T.; Sjoblem, J.; Saeten, J.O.; Gestblom, B. Solubilization of drugs in microemulsions as studied by dielectric spectroscopy. J. Colloid Interface Sci., 1993, 155, 392-401.
59. Aboofazeli, R.; Lawrence, M.J. Investigations into the formation and characterization of phospholipid microemulsions: I Pseudo-ternary phase diagrams of systems containing water-lecithin-alcohol-isopropyl myristate. Int. J. Pharm., 1993, 93, 161-175.
60. Schurtenberger, P.; Peng, Q.; Leser, M.; Luisi, P.L. Structure and phase behavior of lecithin-based microemulsions: a study of chain length dependence. J. Colloid Interface Sci., 1993, 156, 43-51.
61. Kitistis, G.; Niopas, I. A study on the in vitro percutaneous absorption of propranolol from disperse system. J. Pharm. Pharmacol., 1998, 50, 413-419.
62. Attwood, D.; Ktistis, G.; McCormick, Y.; Story, M.J. Solubiliza-tion of indomethacin by polysorbate 80 in mixed water-sorbitol solvents. J Pharm. Pharmacol., 1989, 41, 83-6.
63. Reiss, H. Entropy-induced dispersion of bulk liquids. J. Colloid Interface. Sci., 1975, 53, 61-70.
64. Groves, M.J.; Galindez, D.A.D. The self-emulsifying action of mixed surfactants in oil. Acta. Pharma. Suecica., 1976b, 13, 361-372.
65. Groves, M.J., Mustafa, R.M.A. Measurement of the spontaneity of self emulsifiable oils. J. Pharm. Pharmcol., 1974, 26, 671-681.
66. Pouton, C.W. Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int. J. Pharm., 1985, 27, 335-348.
67. Lijuan, W.; Jinfeng, D.; Jing, C.; Julian, E.; Xuefeng, Li. Design and optimization of a new self-nanoemulsifying drug delivery system. J. Colloid Interface. Sci., 2009, 330, 443-448.
68. Komatsu, H.; Kitajima, A.; Okada, S. Pharmaceutical characterization of commercially available intravenous fat emulsions: Estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem. Pharm. Bull., 1995, 43, 1412-11415.
69. Washington, C. The stability of intravenous fat emulsions in total parenteral nutrition mixtures. Int. J. Pharm., 1990, 66, 1-21.
70. Patil, P.; Joshij J.; Paradkar, P. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS Pharm. Sci Tech., 2004, 5, 34-42.
71. Patil, P.; Vandana, P.; Paradkar, P. Formulation of self-emulsifying drug delivery system for oral delivery of simvastatin: In vitro and in vivo evaluation. Acta. pharma., 2007, 57, 111-122.
72. Groves, M.J.; Galindez, D.A D. Rheological characterization of self-emulsifying oil/surfactant systems. Acta. Pharma. Suecica., 1976a, 13, 353-360.
73. Angelico, R.; Palazzo, G.; Colafemmina, G.; Cirkel, P.A., Giustini, M.; Ceglie, A. Water diffusion and head group mobility in polymer-like reverse micelles: evidence of a sphere-to-rod-to-sphere transition. J. Phys. Chem., 1998, 102, 2883-2889.
74. Yu, Z.J.; Neuman, R.D. Reversed micellar solution-to-bicontinuous microemulsion transition in sodium bis(2-ethylhexyl) phosphate/n-heptane/water system. Langmuir., 1995, 11, 1081-1086.
75. Willimann, H.; Walde, P.; Luisi, P.L.; Gazzaniga, A.; Stroppolo, F. Lecithin organogels as matrix for transdermal transport of drugs. J. Pharm. Sci., 1992, 81, 871-874.
76. Kantaria, S.; Rees, G.D.; Lawrence, M.J. Gelatin-stabilized micro-emulsion-based organogels: rheology and application in iontopho-retic transdermal drug delivery. J. Control. Rel., 1999, 60, 355-365.
77. Trotta, M.; Morel S.; Gasco, M.R. Effect of oil phase composition on the skin permeation of felodipine from (o/w) microemulsions. Phamiazie., 1997, 52, 50-53.
78. Eastoe, J.; Gazelles, B.M.H.; Steytler, D.C.; Holmes, J.D.; Pitt, A.R; Wear, T.J.; Heenan, R.K. Water-in-C02 microemulsions studied by small-angle neutron scattering. Langmuir., 1997, 13, 6980-6984.
79. Kushima, Y.; Saito, N.; Hatakeda, K.; Arai, M. Water/AOT/ethane microemulsion under supercritical conditions as a reaction medium. J. Supercrit. Fluids., 1988, 13, 217-224.
80. Rosano, H.L.; Cavello, J.L.; Chang, D.L.; Whittham, J.H. Microe-mulsions: a commentary on their preparation. J. Soc. Cosmet. Chem., 1998, 39, 201-209.
81. Cirkel, P.A.; van der Ploeg, J.P.M.; Koper, G.J.M. Branching and percolation in lecithin wormlike micelles studied by dielectric spec-troscopy. Phys. Rev., 1998, E57, 6875-6883.
82. Feldman, Y.; Kozlovich, N.; Nir, I.; Garti, N. Dielectric spectros-copy of microemulsions. Colloids Surfaces A: Physicochem. Eng. Aspects., 1997, 128, 47-61.
83. Dissado, L.A.; Rowe, R.C.; Hadar, A.; Hill, R.M. The characterization of heterogeneous gels by a dielectric technique: 1. Theory and preliminary evaluation. J. Colloid Interface Sci., 1987, 117, 310-324.
84. Rowe, R.C.; Dissado, L.A.; Zaidi, S.H.; Hill, R.M. The characterization of heterogeneous gels by means of a dielectric technique: 2. Formulation and structural considerations. J. Colloid Interface Sci., 1988, 122, 354-366.
85. Hill, R.M.; Beckford, E.S.; Rowe, R.C.; Jones, C.B., Dissado, L.A. The characterization of oil in water emulsions by means of a dielectric technique. J. Colloid interface Sci., 1990, 138, 521-533.
86. Shafiq, S.; Talegaonkar, S.; Ahmad, F.J.; Khar, R.K.; Ali, M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm., 2007; 66: 227-243.
87. Zangenberg, N.H.; Mullertz, A.; Kristensen, H.G.; Hovgaard, L. A dynamic in vitro lipolysis model. II: evaluation of the model. Eur. J. Pharm. Sci., 2001, 14: 237-244.
88. Kostewicz, E.S.; Wunderlich, M.; Brauns, U.; Becker, R.; Bock, T.; Dressman, J.B. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J. Pharm. Pharmacol., 2004, 56: 43-51.
89. Palin, K.J.; Wilson, C.G.; Davis, S.S.; Phillips, A.J. The effect of oils on the lymphatic absorption of DDT. Int. J. Pharm., 1982, 34, 707-710.
90. Charman, W.N.; Noguchi, T.; Stella, V.J. An experimental system designed to study the in situ intestinal lymphatic transport of lipo-philic drugs in anesthetized rats. Int. J. Pharm., 1986, 33, 155-164.
91. Caliph, S.M.; Charman, W.N.; Porter, C.J.H. Effect of short-, medium-, and long-chain fatty acid based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci., 2000, 89, 1073-1084.
92. Holm, R.; Mullertz, A.; Pedersen, G.P.; Kristensen, H.G. Comparison of the lymphatic transport of halofantrine administered in dispersed systems containing three different unsaturated fatty acids. Pharm. Res., 2001, 18, 1299-1304.
93. Constantinides, P.P.; Scalart, J.P. Formulation and physical characterization of water-in-oil microemulsions containing long versus medium chain length glycerides. Int. J. pharm., 1997, 158, 57-68.
94. Sarciaux, J.M.; Acar, L.; Sado, P.A. Using microemulsion formulations for drug delivery of therapeutic peptides. Int. J. Pharm., 1995, 120, 127-136.
95. Cavalli, R.; Caputo, O.; Carlotti, M. E.; Trotta, M.; Scamecchia, S.; Gasco, M.R. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int. J. Pharm., 1997, 148, 47-54.
96. Gasco, M.R.; Cavalli, R.; Carlotti, M.E. Timolol in lipospheres. Pharmazie., 1992, 47, 119-121.
97. Morel, S.; Gasco, M.R., Cavalli, R. Incorporation in lipospheres of [D-Trp-61] LHRH. Int. J. Pharm., 1994, 105, R1-R3.
98. Carpignano, R.; Gasco, M.R.; Morel, S. Optimization of doxombi-cine incorporation and of the yield of polybutylcyanoacrylate nanoparticles. Pharm. Acta Helv., 1991, 66, 28-32.
99. Gasco, M.R.; Morel, S.; Trotta, M.; Viano, I. Doxombicine englobed in polybutylcyanoacrylate nanocapsules: behavior in vitro and in vivo. Pharm. Acta Helv., 1991, 66, 47-49.
100. Ritschel, W.A.; Adolph, S.; Ritchel, G.B.; Schroeder, T. Improvement of peroral absorption of Cyclosporin A by microemulsions. Methd. Find. Exp. Clin. Pharmacol., 1990, 12, 127-134.
101. Friman, S.; Backmann, L. A new microemulsion formulation of Cyclosporine. Clin. Pharmacokinet., 1996, 30, 181-193.
102. ®). Drugs., 1995, 50, 924-941.
103. Levy, G.; Grant, D. Potential for Cs A-Neoral in organ transplantation. Transplantation Proceedings., 1994, 26, 2932-2934.
104. Kovarik, J.M., Mueller, E.A.; van Bree, J.B.; Tetzloff, W.; Kutz, K. Reduced inter and intra individual variability in Cyclosporine pharmacokinetics from a microemulsion formulation. J. Pharm. Sci., 1994, 83, 444-446.
105. Mueller, E.A.; Kovarik, J.M.; van Bree, J.B.; Tetzloff, W.; Grevel, J.; Kutz, K. Improved dose linearity of Cyclosporine pharmacoki-netics from a microemulsion formulation. Pharm. Res., 1994, 11, 301-304.
106. Ritschel, W.A. Microemulsions for improved peptide absorption from the gastrointestinal tract. Meth. Find. Exp. Clin. Pharmacol., 1991, 13, 205-220.
107. Ritschel, W.A. Microemulsions for improved peptide absorption from the gastrointestinal tract. Meth. Find. Exp. Clin. Pharmacol., 1993, 13, 205-220.
108. Woo, J.S.; Suh H.J. Oral micro-emulsion composition of silybin. WO Patent No. 0101 961, 2001.
109. Cui, S.M.; Zhao, C.S.; Tang, X.; Chen, D.W.; He, Z.G. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry. Biomed. Chromatogra-phy, 2005, 19, 375-8.
110. Cui, S.M.; Zhao, C.S.; Chen, D.W.; He, Z.G. Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isofla-vone. Drug Dev. Ind. Pharm., 2005, 31, 349-56.
111. Kleijnen J, Knipschild P. Lancet., 1992, 340, 1136-9.
112. Kressmann, S.; Biber, A.; Wonnemann, M.; Schug, B.; Blume, H.H.; Muller, W.E. Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations. J. Pharm. Pharmacol., 2002, 54, 1507-14.
113. Kressmann, S.; Müller, W.E.; Blume, H.H. Pharmaceutical quality of different Ginkgo biloba brands. J. Pharm. Pharmacol., 2002, 54, 661-9.
114. Tang, J.L.; Sun, J.; Sun, Y.H.; Cui, F.D.; He, Z.G.; Chroma-tographia., 2006, 63, 53-8.
115. Shah, N.H.; Carvajal, M.T.; Patel, C.I; Infeld, M.H.; Malick, A.W. Self-emulsifying drug delivery systems (SEDDS) with polyglyco-lyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm., 1994, 106, 15-23.
116. Gao, P.; Guyton, M.E.; Huang, T.; Bauer, J.M.; Stefanski. K.J; Qun, L. Enhanced oral bioavailability of a poorly water soluble drug PNU- 91325 by supersaturable formulations. Drug Dev. Ind. Pharm., 2004, 30, 221-229.
117. Charman, S.A.; Charman, W.A.; Rogge, M.C. Self-emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm Res., 1992, 9, 87-93.
118. Kommuru, T.R.; Gurley, B.; Khan, M.A.; Reddy, I.K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm., 2001, 212, 233-246.
119. Shah, N.H.; Carjaval, M.T.; Patel, C.I.; Infeld, M.H.; Malick, A.W. Self-emulsifying drug delivery systems (SEDDS) with polyglyco-lyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm., 1994, 106, 15-23.
120. Kim, J.Y.; Ku, Y.S. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats. Int. J. Pharm., 2000, 174, 81-89.
121. Wu, W.; Wang, Y.; Que, L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm., 2006, 63, 288-294.
122. Shen, H.; Zhong, M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol., 2006, 58, 1183-1191.
123. Hong, J.Y.; Kim, J.K.; Song, Y.K.; Park, J.S.; Kim, C.K. A new self emulsifying formulation of itroconazole with improved dissolution and oral absorption. J. Control. Release., 2006, 110, 332-338.
124. Sek, L.; Boyd, B.J.; Charman, W.N.; Porter, C.J.H. Examination of the impact of a range of Pluronic surfactants on the in vitro solubi-lisation behavior and oral bioavailability of lipidic formulations of atovaquone. J. Pharm. Pharmacol., 2006, 58, 809-820.
125. Yap, S.P.; Yuen, K.H. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int. J. Pharm., 2004, 281, 67-78.
126. Wei, L.; Sun, P.; Nie, S.; Pan, W. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol, Drug Dev. Ind. Pharm., 2005, 31, 785-794.
127. Iwanaga, K.; Kushibiki, T.; Miyazaki, M.; Kakemi, M. Disposition of lipid based formulation in the intestinal tract affects the absorption of poorly water soluble drugs. Biol. Pharm. Bull., 2006, 29, 508-512.
128. Kang, B.K.; Lee, J.S.; Chon, S.K.; Jeong, S.Y.; Yuk, S.H.; Khang, G.; Lee, H.B.; Cho, S.H. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm., 2004, 274, 65-73.
129. Julianto, T.; Yuen, K.H.; Mohammad Noor, A. Improved bioavail-ability of vitamin E with a self-emulsifying formulation. Int. J. Pharm., 2000, 200, 53-57.
130. Trull, A.K.; Tan, K.K.C.; Tan, L.; Alexander, G.J.M.; Jamieson, N.V. Enhanced absorption of new oral Cyclosporine microemul-sion formulation, Neoral, in liver transplant recipients with external biliary diversion. Transplant. Proc., 1994, 26, 2977-2978.
131. Hauss, D.J.; Fogal, S.E.; Ficorilli, J.V.; Price, C.A.; Roy, T.; Jayaraj, A.A.; Keirns, J.J. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci., 1998, 87, 164-169.
132. Tuleu, C.; Newton, M. Rose, J.; Euler, D.; Saklatvala, R. Clarke, A.; Booth, S. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J. Pharm. Sci., 2004, 93, 1495-1502.
133. Kim, C.K.; Cho, Y.J.; Gao, Z.G. Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. J. control. Release., 2001, 70, 149-155.
134. Araya, H.; Nagao, S.; Tomita, M.; Hayashi, M. The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type o/w microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs. Drug Metab. Pharmacokinet., 2005, 20, 244-256.